Contact
searchSearch
HMP Global

Pharmacy Learning Network

PharmLaw

PharmLaw
Jefferson Health Alleges Insulin Rebate Scheme Between PBMs and Drugmakers
01/09/2026
Juliet Gallagher
A major nonprofit health system has filed a federal lawsuit accusing leading insulin manufacturers and pharmacy benefit managers (PBMs) of conspiring to inflate insulin prices through rebate-driven pricing practices that allegedly harm...
A major nonprofit health system has filed a federal lawsuit accusing leading insulin manufacturers and pharmacy benefit managers (PBMs) of conspiring to inflate insulin prices through rebate-driven pricing practices that allegedly harm...
A major nonprofit health system...
01/09/2026
Pharmacy Learning Network
PharmLaw
West Virginia Files Lawsuit Alleging Optum’s PBM Practices Contributed to Opioid Crisis
12/10/2025
Danielle Sposato
West Virginia has sued Optum, alleging the PBM’s rebate-driven formulary practices, manufacturer collaborations, data sharing, mail-order dispensing, and discount card programs contributed to the state’s opioid crisis. The lawsuit seeks...
West Virginia has sued Optum, alleging the PBM’s rebate-driven formulary practices, manufacturer collaborations, data sharing, mail-order dispensing, and discount card programs contributed to the state’s opioid crisis. The lawsuit seeks...
West Virginia has sued Optum,...
12/10/2025
Pharmacy Learning Network
PharmLaw
CVS to Pay $37.76 Million to Resolve Federal Allegations of Over-Dispensing Insulin Pens
12/05/2025
Danielle Sposato
The US Attorney’s Office for the Southern District of New York has announced a $37.76 million settlement with CVS Pharmacy, Inc. to resolve allegations that the company violated the False Claims Act by over-dispensing insulin pens and...
The US Attorney’s Office for the Southern District of New York has announced a $37.76 million settlement with CVS Pharmacy, Inc. to resolve allegations that the company violated the False Claims Act by over-dispensing insulin pens and...
The US Attorney’s Office for the...
12/05/2025
Pharmacy Learning Network
PharmLaw
FTC Action Against Caremark & Zinc Health Services Sparks Proposed Regulatory Overhaul of Insulin Pricing Practices
11/26/2025
Danielle Sposato
The Federal Trade Commission’s enforcement action against Caremark Rx, LLC, Zinc Health Services, LLC, and related entities—which centers on how pharmacy benefit managers (PBMs) and their affiliated group purchasing organizations (GPOs)...
The Federal Trade Commission’s enforcement action against Caremark Rx, LLC, Zinc Health Services, LLC, and related entities—which centers on how pharmacy benefit managers (PBMs) and their affiliated group purchasing organizations (GPOs)...
The Federal Trade Commission’s...
11/26/2025
Pharmacy Learning Network
PharmLaw
Purdue Pharma Bankruptcy Plan Approved: $7.4 Billion Settlement Marks Turning Point in Opioid Accountability
11/18/2025
Danielle Sposato
NEW YORK — In a major step toward resolving one of the most consequential public health lawsuits in U.S. history, US Bankruptcy Judge Sean Lane has approved Purdue Pharma’s bankruptcy plan, finalizing a $7.4 billion settlement between the...
NEW YORK — In a major step toward resolving one of the most consequential public health lawsuits in U.S. history, US Bankruptcy Judge Sean Lane has approved Purdue Pharma’s bankruptcy plan, finalizing a $7.4 billion settlement between the...
NEW YORK — In a major step...
11/18/2025
Pharmacy Learning Network

FDA Recalls

News
BD ChloraPrep Triple Swabsticks Recalled Due to Sterility Concerns
01/07/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for BD ChloraPrep Triple Swabsticks due to a lack of sterility assurance, potentially compromising infection control in preoperative and clinical use.
The US Food and Drug Administration (FDA) has issued a Class II recall for BD ChloraPrep Triple Swabsticks due to a lack of sterility assurance, potentially compromising infection control in preoperative and clinical use.
The US Food and Drug...
01/07/2026
Pharmacy Learning Network
News
Class II Recall for Ondansetron Orally Disintegrating Tablets Due to Packaging Defect
01/07/2026
Hannah Musick
A Class II recall for Ondansetron Orally Disintegrating Tablets has been issued due to defective blister packaging that may allow tablets to fall out, potentially compromising product integrity and dosing accuracy.
A Class II recall for Ondansetron Orally Disintegrating Tablets has been issued due to defective blister packaging that may allow tablets to fall out, potentially compromising product integrity and dosing accuracy.
A Class II recall for...
01/07/2026
Pharmacy Learning Network
News
FDA Issues Class II Recall for Wegovy (Semaglutide) Prefilled Pens Due to Contamination
01/07/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for select Wegovy (semaglutide) prefilled pens after hair was found inside syringes, raising concerns about particulate contamination in the injectable product.
The US Food and Drug Administration (FDA) has issued a Class II recall for select Wegovy (semaglutide) prefilled pens after hair was found inside syringes, raising concerns about particulate contamination in the injectable product.
The US Food and Drug...
01/07/2026
Pharmacy Learning Network
News
Class II Recall Issued for Ganirelix Injection After Detection of Degradation Impurity
12/18/2025
Juliet Gallagher
Lupin Pharmaceuticals has initiated a voluntary recall of Ganirelix Acetate Injection 250 mcg/0.5 mL, supplied in single-dose sterile prefilled syringes. The affected lot, WB00006, carries an expiration date of December 31, 2026 and includes...
Lupin Pharmaceuticals has initiated a voluntary recall of Ganirelix Acetate Injection 250 mcg/0.5 mL, supplied in single-dose sterile prefilled syringes. The affected lot, WB00006, carries an expiration date of December 31, 2026 and includes...
Lupin Pharmaceuticals has...
12/18/2025
Pharmacy Learning Network
News
Fagron Recalls Compounded Ophthalmic Syringes Over Incorrect Formulation
12/18/2025
Juliet Gallagher
Fagron Sterile Services has voluntarily recalled one lot of its Tropicamide 1% / Cyclopentolate 1% / Phenylephrine 2.5% / Ketorolac 0.5% topical ophthalmic solution, supplied in 0.5 mL single-use syringes.
Fagron Sterile Services has voluntarily recalled one lot of its Tropicamide 1% / Cyclopentolate 1% / Phenylephrine 2.5% / Ketorolac 0.5% topical ophthalmic solution, supplied in 0.5 mL single-use syringes.
Fagron Sterile Services has...
12/18/2025
Pharmacy Learning Network

In the News

PharmLaw
Jefferson Health Alleges Insulin Rebate Scheme Between PBMs and Drugmakers
01/09/2026
Juliet Gallagher
A major nonprofit health system has filed a federal lawsuit accusing leading insulin manufacturers and pharmacy benefit managers (PBMs) of conspiring to inflate insulin prices through rebate-driven pricing practices that allegedly harm...
A major nonprofit health system has filed a federal lawsuit accusing leading insulin manufacturers and pharmacy benefit managers (PBMs) of conspiring to inflate insulin prices through rebate-driven pricing practices that allegedly harm...
A major nonprofit health system...
01/09/2026
Pharmacy Learning Network
News
BD ChloraPrep Triple Swabsticks Recalled Due to Sterility Concerns
01/07/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for BD ChloraPrep Triple Swabsticks due to a lack of sterility assurance, potentially compromising infection control in preoperative and clinical use.
The US Food and Drug Administration (FDA) has issued a Class II recall for BD ChloraPrep Triple Swabsticks due to a lack of sterility assurance, potentially compromising infection control in preoperative and clinical use.
The US Food and Drug...
01/07/2026
Pharmacy Learning Network
News
Class II Recall for Ondansetron Orally Disintegrating Tablets Due to Packaging Defect
01/07/2026
Hannah Musick
A Class II recall for Ondansetron Orally Disintegrating Tablets has been issued due to defective blister packaging that may allow tablets to fall out, potentially compromising product integrity and dosing accuracy.
A Class II recall for Ondansetron Orally Disintegrating Tablets has been issued due to defective blister packaging that may allow tablets to fall out, potentially compromising product integrity and dosing accuracy.
A Class II recall for...
01/07/2026
Pharmacy Learning Network
News
FDA Issues Class II Recall for Wegovy (Semaglutide) Prefilled Pens Due to Contamination
01/07/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for select Wegovy (semaglutide) prefilled pens after hair was found inside syringes, raising concerns about particulate contamination in the injectable product.
The US Food and Drug Administration (FDA) has issued a Class II recall for select Wegovy (semaglutide) prefilled pens after hair was found inside syringes, raising concerns about particulate contamination in the injectable product.
The US Food and Drug...
01/07/2026
Pharmacy Learning Network
News
Class II Recall Issued for Ganirelix Injection After Detection of Degradation Impurity
12/18/2025
Juliet Gallagher
Lupin Pharmaceuticals has initiated a voluntary recall of Ganirelix Acetate Injection 250 mcg/0.5 mL, supplied in single-dose sterile prefilled syringes. The affected lot, WB00006, carries an expiration date of December 31, 2026 and includes...
Lupin Pharmaceuticals has initiated a voluntary recall of Ganirelix Acetate Injection 250 mcg/0.5 mL, supplied in single-dose sterile prefilled syringes. The affected lot, WB00006, carries an expiration date of December 31, 2026 and includes...
Lupin Pharmaceuticals has...
12/18/2025
Pharmacy Learning Network

Subscribe Today

Pharmacy Learning Network Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use